Demethylation of the CD133 gene has been found in a variety of human tumors including colorectal cancer [26], gastric carcinoma [27], gliomas and glioblastoma [28,29], HCC [30], and ovarian cancer [31] and so on. This evidence concerns the gene PROM1 and colorectal cancer.